IMPACT OF FIXED-DOSE 4F-PCC ON TIME TO ADMINISTRATION FOR ANTICOAGULATION REVERSAL IN THE ED

被引：0
作者：
DeFilippo, Nicholas [1 ]
Jones, Kerri [1 ]
Pournezhad, Sam [2 ]
Patka, John [1 ]
Chester, Katleen [2 ]
Morrison, Christopher [1 ]
机构：
[1] Grady Mem Hosp, Atlanta, GA USA
[2] Grady Hlth Syst, Emeryville, CA USA
来源：
CRITICAL CARE MEDICINE | 2023年 / 51卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
1007
引用
收藏
页码：497 / 497
页数：1
相关论文
共 50 条
  • [21] IMPACT OF TIMING OF 4F-PCC ADMINISTRATION ON OUTCOMES IN ORAL FACTOR XA INHIBITOR-ASSOCIATED ICH
    Jaszcz, Sarah
    Wein, Rachel
    Mangan, Kyle
    Mohamed, Wazim
    Parker, Dennis
    [J]. CRITICAL CARE MEDICINE, 2025, 53 (01)
  • [22] THROMBOTIC COMPLICATIONS FOLLOWING 4F-PCC FOR WARFARIN REVERSAL IN MECHANICAL HEART VALVE PATIENTS
    Lewis, Elizabeth
    Ice, Calvin
    Steensma, Elizabeth
    Saunders, Rachel
    Parker, Jessica
    [J]. CRITICAL CARE MEDICINE, 2020, 48
  • [23] COMPARISON OF 4F-PCC FOR REVERSAL OF DOAC VERSUS WARFARIN-ASSOCIATED INTRACRANIAL HEMORRHAGE
    Pasciolla, Stacy
    Wojcik, Kevin
    Evans, Danielle
    Shaikh, Hamza
    Jankowitz, Brian
    Igneri, Lauren
    [J]. CRITICAL CARE MEDICINE, 2021, 49 (01) : 352 - 352
  • [24] SAFETY OF FOUR FACTOR PROTHROMBIN COMPLEX CONCENTRATES (4F-PCC) FOR THE REVERSAL OF FACTOR XA INHIBITORS
    Tao, Jing
    Bukanova, Elena
    Akhtar, Shamsuddin
    [J]. ANESTHESIA AND ANALGESIA, 2018, 126 (04) : 98 - 100
  • [25] Safety of 4-factor prothrombin complex concentrate (4F-PCC) for emergent reversal of factor Xa inhibitors
    Tao, Jing
    Bukanova, Elena N.
    Akhtar, Shamsuddin
    [J]. JOURNAL OF INTENSIVE CARE, 2018, 6
  • [26] COMPARISON OF 4F-PCC AND ANDEXANET ALFA FOR REVERSAL OF APIXABAN- AND RIVAROXABAN-ASSOCIATED ICH
    Lipski, Michelle
    Pasciolla, Stacy
    Wojcik, Kevin
    Jankowitz, Brian
    Igneri, Lauren
    [J]. CRITICAL CARE MEDICINE, 2022, 50 (01) : 378 - 378
  • [27] 4F-PCC FOR REVERSAL OF DIRECT-ACTING ORAL ANTICOAGULANTS FOR MAJOR BLEEDS OR EMERGENT SURGERY
    Berger, Karen
    Lin, Lina
    Lesch, Christine
    [J]. CRITICAL CARE MEDICINE, 2016, 44 (12)
  • [28] FIXED-DOSE FOUR-FACTOR PCC FOR THE REVERSAL OF FACTOR XA INHIBITOR-ASSOCIATED BLEEDING
    Cycz, Clare
    Philips, Eli
    Elsamadisi, Pansy
    [J]. CRITICAL CARE MEDICINE, 2023, 51 (01) : 155 - 155
  • [29] A Low-Dose 4F-PCC Protocol for DOAC-Associated Intracranial Hemorrhage
    Berger, Karen
    Santibanez, Melissa
    Lin, Lina
    Lesch, Christine A.
    [J]. JOURNAL OF INTENSIVE CARE MEDICINE, 2020, 35 (11) : 1203 - 1208
  • [30] EVALUATION OF 4F-PCC IN OBESE VERSUS NON-OBESE PATIENTS FOR FACTOR XA INHIBITOR REVERSAL
    Ciborowski, Megan
    Nakajima, Steven
    Sparks, Eric
    McKinney, James, III
    [J]. CRITICAL CARE MEDICINE, 2020, 48
12345